Out of stock

This item is currently unavailable

The 2025-2030 World Outlook for Psoriatic Arthritis Therapeutics

Out of stock

Price data last checked 30 day(s) ago - will refresh soon

View at Amazon

One email. No newsletter. No nudges.

Out of stock for 30 days. The last 3 returns each lasted under a day — get on the list.

Out of stock 30 days · usually back within 14 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

No price data yet

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
09 April 2024

Similar Products You Might Like

The 2023-2028 Outlook for Psoriatic Arthritis Treatments in the United States
98% match

The 2023-2028 Outlook for Psoriatic Arthritis Treatments in the United States

£520.00 16 Jul 2026
The 2023-2028 World Outlook for Systemic Psoriasis Therapeutics
98% match

The 2023-2028 World Outlook for Systemic Psoriasis Therapeutics

£795.00 25 Jun 2026
The 2023-2028 World Outlook for Interleukin Blockers for Psoriasis Treatments
97% match

The 2023-2028 World Outlook for Interleukin Blockers for Psoriasis Treatments

Price unavailable
The 2025-2030 World Outlook for Rheumatoid Arthritis Treatments
97% match

The 2025-2030 World Outlook for Rheumatoid Arthritis Treatments

Price unavailable
The 2025-2030 World Outlook for Anti-Inflammatory Scleroderma Drugs
96% match

The 2025-2030 World Outlook for Anti-Inflammatory Scleroderma Drugs

Price unavailable
96% match

Psoriatic Arthritis Updates, An Issue of Rheumatic Disease Clinics of North America (Volume 51-3) (The Clinics: Internal Medicine, Volume 51-3)

Elsevier

£77.26 08 Jul 2026
The 2023-2028 Outlook for Rheumatoid Arthritis Treatments in China
96% match

The 2023-2028 Outlook for Rheumatoid Arthritis Treatments in China

£495.00 11 Jul 2026
The 2023 Report on Psoriasis Medicines: World Market Segmentation by City
96% match

The 2023 Report on Psoriasis Medicines: World Market Segmentation by City

£795.00 14 Jul 2026
The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in India
96% match

The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in India

£515.00 25 Jun 2026
The 2023-2028 Outlook for Rheumatoid Arthritis Treatments for US Zip Codes
96% match

The 2023-2028 Outlook for Rheumatoid Arthritis Treatments for US Zip Codes

£490.00 01 Jul 2026
Tailored Treatments in Psoriatic Patients
96% match

Tailored Treatments in Psoriatic Patients

IntechOpen

£100.00 10 Jul 2026
The 2025-2030 World Outlook for Autoimmune Disease Diagnostic Consumables and Assay Kits
95% match

The 2025-2030 World Outlook for Autoimmune Disease Diagnostic Consumables and Assay Kits

Price unavailable
The 2023-2028 World Outlook for Ophthalmic Anti-Inflammatory Pharmaceutical Drugs
95% match

The 2023-2028 World Outlook for Ophthalmic Anti-Inflammatory Pharmaceutical Drugs

£795.00 10 Jul 2026
Advances in Psoriasis: A Multisystemic Guide
95% match

Advances in Psoriasis: A Multisystemic Guide

Springer

£88.47 07 Jul 2026
Nutraceuticals in Arthritis and Psoriasis: Management and Prevention of Diseases (AAP Advances in Nutraceuticals)
95% match

Nutraceuticals in Arthritis and Psoriasis: Management and Prevention of Diseases (AAP Advances in Nutraceuticals)

£159.19 16 Jul 2026
The 2023-2028 Outlook for Ophthalmic Anti-Inflammatory Pharmaceutical Drugs in the United States
95% match

The 2023-2028 Outlook for Ophthalmic Anti-Inflammatory Pharmaceutical Drugs in the United States

£520.00 24 Jun 2026